3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients

I. R. N. Verly, A. B. P. van Kuilenburg, N. G. G. M. Abeling, S. M. I. Goorden, M. Fiocco, F. M. Vaz, M. M. van Noesel, C. M. Zwaan, G. J. L. Kaspers, J. H. M. Merks, H. N. Caron, G. A. M. Tytgat

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)102-110
JournalEuropean Journal of Cancer
Volume90
DOIs
Publication statusPublished - Feb 2018

Cite this

Verly, I. R. N., van Kuilenburg, A. B. P., Abeling, N. G. G. M., Goorden, S. M. I., Fiocco, M., Vaz, F. M., ... Tytgat, G. A. M. (2018). 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients. European Journal of Cancer, 90, 102-110. https://doi.org/10.1016/j.ejca.2017.11.025